MannKind Corporation
MannKind Corporation was founded in 1991 and is headquartered in Valencia, California. MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diseases, such as diabetes and cancer. Its lead product candidate, AFRESA, a rapid-acting insulin that has completed phase 3 clinical trials for the treatment of diabetes in the United States, Europe, and Japan. The company's lead product candidates also include MKC1106-PP, which is in phase I clinical trial for the treatment of various solid-tumor cancers, including ovarian, colorectal, pancreatic, renal, breast, non-small cell lung and prostate carcinomas, glioblastoma, and melanoma.
Contact Details
Office Address
MannKind Corporation
Corporate Headquarters 28903 North Avenue Paine
Valencia, CA, USA 91355
Phone: (661) 775-5300
Executives
Founder, Chairman and Chief Exec. Officer
Mr. Alfred E. Mann
Chief Operating Officer
Mr. Hakan S. Edstrom